Real-world evidence of Besponsa in Belgium in acute lymphoblastic leukemia patients according to the prevailing reimbursement criteria Last updated: 2023-05-25 18:01
Collection of real-world evidence for the medicine Prevymis in the context of an article 112 of the Royal Decree of 01/02/2018 (managed entry agreement) with a pay-for-performance mechanism Last updated: 2022-04-08 13:58